Markets at life time highs, likely to consolidate before next up move

Markets continued to gain ground and make new life-time highs on the benchmark indices. BSESENSEX gained 1,549.94 points or 3.70% to close at 43,443.00 points while NIFTY gained 454.40 points or 3.72% to close at 12,719.95 points. The broader market saw BSE100, BSE200 and BSE500 gain 3.74%, 3.60% and 3.53% respectively. BSEMIDCAP was up 3.06% while BSESMALLCAP was up 2.77%. Markets gained on four of the five trading sessions.

Muhurat trading for Samvat 2077 held on Saturday the 14th of November saw brisk and optimistic trading. BSESENSEX gained 194.98 points while NIFTY gained 60.30 points making the benchmark indices hit new lifetime highs yet again.

What does Samvat 2077 have in store for the market? Going by previous trends on Muhurat day it can be said that well begun is half done. We have started on a positive note. The government is taking measures and trying to do its best to kickstart the economy on many fronts. While there would always be one section which is not satisfied that enough has not been done, in reality a lot has been done and it is likely to yield results going forward.

Take for example the auto industry. They were in dire straits and things seemed to be really bad for them. Covid-19 has turned out to be a blessing in disguise with the need for personal mobility becoming the need of the hour. Two wheelers and entry level passenger cars are selling like hot cakes and the demand is seemingly never ending.

The government has also announced far reaching measures for the real estate industry. These measures should see the industry experiencing revival in demand and developers restarting stalled projects.

Let us see what the previous year Samvat 2076 did for the markets. On Muhurat day Samvat 2076 saw BSESENSEX gain 192.14 points while NIFTY gained 43.20 points. There was doble digit returns on the BSESENSEX with it rising from 39,058.06 to 43,443 points, a rise of 4,384.94 points or 11.23%. NIFTY rose from 11,583.90 points to 12,719.95 points, to gain 1,136.05 points or 9.81%. Pharma shares had an excellent run. Dr Roddy’s was up about 75% while Cipla, Sun Pharma and others chipped in with gains between 25-50%. Reliance Industries had a spectacular run post covid-19 and rose from a low of Rs 868 to a high of Rs 2,370. However, on a Samvat year basis it gained 41%.

The Indian Rupee lost 40 paisa or 0.54% to close at Rs 74.60 to the US Dollar. Dow Jones hit a new lifetime high and gained 1,156.41 points or 4.08% to close at 29,479.81 points. The high that Dow Jones hit was at 29,933.83 points beating the previous 29,551.42 points recorded on 12th February 2020. In US elections the last state has been called and the final tally would appear to be 306-232, a similar number to what had happened in 2016 when Donald Trump had beaten Hilary Clinton. While Donald Trump is still contesting some states, it seems to be delaying tactics more than anything else.

The public issue from Gland Pharma was subscribed 2.06 times on the back of institutional support who subscribed their portion by 6.40 times. Non institutional portion remained undersubscribed with HNI at 0.51 times and Retail at 0.24 times. The company had tapped the capital markets with its fresh issue of Rs 1,250 crs and an offer for sale of 3.48 cr shares in a price band of Rs 1,490-1500. The issue would list on Friday the 20th of November.

The buoyancy in the capital markets could be attributed to the liquidity in the system and also to the measures being periodically announced by the government to kickstart the economy. FII’s have in the present month of November till date bought equity worth Rs 33,232 crs while Domestic institutions have sold equity worth Rs 20,301 crs.

In the current November series NIFTY has gained 1,049.15 points or 8.99% and we still have 8 trading sessions to go before the month or series expires. While the momentum would remain intact and so would the trend, it seems highly unlikely that it happens without consolidation. Market to remain buoyant needs to consolidate at these new lifetime highs before charting further upward movement. Expect the week ahead to witness some of this consolidation happening.

On the covid-19 front, the world saw 5,43,29,104 patients, 13,18,286 deaths and 3,78,71,375 people recovering. In India we saw 88,14,992 patients, 1,29,674 deaths and 82,05,728 patients recovering. During the week the world saw 40,65,146 new patients, 61,932 deaths and 23,21,222 patients recovering. In India we saw 3,07,238 new patients, 3,512 deaths and 3,33,760 patients recovering. As numbers, number of patients recovering is encouraging. However, we need to ensure social distancing strictly as the country continues to unlock.

The week ahead starts with a trading holiday on Monday post Diwali. Expect markets to consolidate in the week ahead. Whether it happens on Tuesday or a day or couple of days later is not as material as the fact that consolidation and spending time at similar levels is. Expect markets to become volatile and experience high intra-day two sided movements with little or no change on an end of day basis. The momentum and trend would remain intact for some more time. The strategy should be to sell into strong rallies and buy on sharp dips. Enjoy the festive times.

Performance of Newly Listed Shares as on 13th November

Name Date of Listing Issue Price Closing Price Closing Price % Gain Loss % Change Over
      131120 061120 Over Week lssue Price
CSB Bank Limited 4th December 195.00 253.40 256.00 -1.02 29.95
Ujjivan Small Finance Bank Limited 12th December 37.00 33.05 32.20 2.64 -10.68
Prince Pipes and Fittings Limited 30th December 178.00 262.85 240.00 9.52 47.67
SBI Card & Payment Services Limited 16th March 755.00 773.85 847.55 -8.70 2.50
Rossari Biotech Limited 23rd July 425.00 765.50 780.85 -1.97 80.12
Mindspace Buisness Parks Reit 7th July 275.00 305.27 305.13 0.05 11.01
Happiest Mind Technologies Ltd 17th September 166.00 321.30 325.90 -1.41 93.55
Route Mobile Limited 21st September 350.00 918.70 925.45 -0.73 162.49
CAMS Limited 1st October 1230.00 1300.60 1280.10 1.60 5.74
Chemcon Speciality Chemicals Limited 1st October 340.00 418.40 444.10 -5.79 23.06
Angel Broking Limited 5th October 306.00 352.15 311.80 12.94 15.08
Mazazgon Dock Shipbuilders Limited 12th October 145.00 183.10 170.15 7.61 26.28
UTI AMC Limited 12th October 554.00 487.15 495.55 -1.70 -12.07
Lithikha Infrastructure Limited 15th October 120.00 157.75 163.35 -3.43 31.46
Equitas Small Finance Bank Limited 2nd November 33.00 34.50 32.90 4.86 4.55

Gland Pharma Limited – Subscribed just over 2 times

The primary market issue from Gland Pharma Limited was subscribed 2.06 times with the support of QIB’s. The non-institutional portion remained undersubscribed.

The company had tapped the capital markets with its fresh issue of Rs 1,250 crs and an offer for sale of 3,48,63,635 equity shares in a price band of Rs 1,490-1500. Earlier the company had allotted 1,29,59,089 shares to 70 anchor investors comprising of 131 entities. The highest allocation was made to Smallcap World Fund who was allotted 8,57,400 shares or 6.62% of the anchor allotment. This was followed by 6,84,300 shares or 5.32% to Government of Singapore.

The issue was open from Monday the 9th of November to Wednesday the 11th of November.

The issue saw QIB’s subscribing the QIB portion 6.4 times. HNI portion was undersubscribed at 0.51 times while Retail portion remained undersubscribed at 0.24 times. There were just under 2 lac applications and the average application size was 1.8 lots or roughly 18 shares.

What went wrong for the issue? There were two broad reasons for the issue receiving poor response from the non-institutional portion. The first reason was the valuation which saw Fosun selling at roughly three times the value it invested three years ago. The PE multiple was 29.87-30.07. What affected investors more was the market cap to sales which was almost ten times, a number unheard of in the pharma sector. The second cause of concern was the fact that the promoters of this company was from China and since the escalation of tension on the Indo-China border there is an anti-China feeling which is growing.

Details of the subscription are given below: –

Gland Pharma Subscription

Bucket Size Shares Applied for Times Oversubscribed
QIB 8639394 55250350 6.40
HNI 6479546 3294470 0.51
Retail

15118939 3610850 0.24
Total

30237879 62155670 2.06
Subscribe to RSS Feed Follow me on Twitter!